Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rezolute Inc (NQ: RZLT )

5.580 -0.140 (-2.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rezolute Inc

< Previous 1 2 3 4 5 Next >
Rezolute to Participate in Upcoming Investor Conferences in September
From Rezolute, Inc.
Via GlobeNewswire
Rezolute And 2 Other Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
What 4 Analyst Ratings Have To Say About Rezolute
Via Benzinga
Rezolute to Initiate a Pivotal Phase 3 Study of RZ358 in Participants 3 Months of Age and Older with Congenital Hyperinsulinism
From Rezolute, Inc.
Via GlobeNewswire
Short Volatility Alert: Rezolute, Inc.
On Tuesday, shares of Rezolute, Inc. (NASDAQ: RZLT) experienced volatile short activity. After the activity, the stock price went down -2.59% to $3.01. The overall sentiment for RZLT has been Bearish. 
Via Benzinga
Rezolute's RZ358 Shows Around 75% Reduction In Hypoglycemia Events
Via Benzinga
Stonegate Healthcare Partners Announces Publishing of a Thematic Report - Beyond VEGF: Therapies Revolutionizing Diabetic Eye Disease
Dallas, Texas--(Newsfile Corp. - June 1, 2023) - Stonegate Healthcare Partners (SHP), a healthcare... 
Via Newsfile
Rezolute Reports Third Quarter Fiscal 2023 Results and Highlights Company Progress
The Company is poised to commence Phase 3 for RZ358 in the third quarter of calendar year 2023 
From Rezolute, Inc.
Via GlobeNewswire
Rezolute KOL Event Highlights Significant Unmet Medical Need in Diabetic Macular Edema
RZ402 is an oral therapy being developed as a potential alternative to anti-vascular growth factor (anti-VEGF) injections into the eye 
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Highlight RZ402 Phase 2 Clinical Program with Leading Clinical Expert
Conference call and webcast to be held on Wednesday, March 22 at 4:30 pm EDT 
From Rezolute, Inc.
Via GlobeNewswire
Rezolute Reports Second Quarter Fiscal 2023 Results and Highlights Company Progress
From Rezolute, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Rezolute Announces Initiation of a Phase 2 Study of RZ402 in Patients with Diabetic Macular Edema
RZ402 is an oral therapy being developed as a potential alternative to invasive and suboptimal injections into the eye 
From Rezolute, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Monday
  On Monday, 297 companies reached new 52-week lows. 
Via Benzinga
Rezolute Reports First Quarter Fiscal 2023 Results and Highlights Company Progress
From Rezolute, Inc.
Via GlobeNewswire
Rezolute to Present at the Jefferies London Healthcare Conference
From Rezolute, Inc.
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 111 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
  On Tuesday, 120 companies set new 52-week lows. 
Via Benzinga
Rezolute Announces Presentation at The Retina Society 55th Annual Scientific Meeting
From Rezolute, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2022
Upgrades 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  During Friday's session, 41 companies made new 52-week lows. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2022
Upgrades 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Natus Medical (NASDAQ:NTUS) stock rose 28.3% to $33.42 during Monday's pre-market session. The market value of their outstanding shares is at $1.1 billion.... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million. 
Via Benzinga
36 Stocks Moving In Friday's Mid-Day Session
Gainers Forge Global Holdings, Inc. (NYSE: FRGE) shares jumped 66.4% to $20.70. Clever Leaves Holdings Inc. (NASDAQ: CLVR) jumped 29.1% to $2.04 after the company reported... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Greenwich LifeSciences (NASDAQ:GLSI) stock moved upwards by 9.6% to $23.84 during Wednesday's after-market session. The market value of their outstanding shares is at $312.8 million. As per the... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Creative Medical Tech (NASDAQ:CELZ) shares rose 78.8% to $3.04 during Wednesday's pre-market session. The market value of their outstanding shares is at $19.2... 
Via Benzinga
58 Biggest Movers From Friday
Gainers BEST Inc. (NYSE: BEST) shares gained 73.6% to close at $1.00. DiDi Global Inc. (NYSE: DIDI) shares jumped 59.8% to settle at $4.09 on Friday. Zhihu Inc. (NYSE: ZH)... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.